Navigation Links
Pfizer Inc and GoIndustry DoveBid Partner to Auction Surplus Equipment from R&D Facilities Across the United States
Date:6/30/2010

BALTIMORE, June 30 /PRNewswire/ -- GoIndustry DoveBid announces the Pfizer asset disposition program, which will see auctions of surplus assets from Pfizer's facilities across the United States. Over 500 lots per week will be available via online auction as part of GoIndustry DoveBid's ongoing BioPharma Exchange, over the upcoming months.

(Logo: http://photos.prnewswire.com/prnh/20100630/PH28915LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20100630/PH28915LOGO )

Each week's auction will include an outstanding selection of assets ranging from HPLC and NMR Systems to Mass Spectrometers and general lab equipment. The majority of assets come from working environments and have been maintained, as one would expect from a top tier company such as Pfizer.

"With GoIndustry DoveBid, we have undergone an extensive project to identify all the surplus assets in our facilities across the country," said Bill Carr, Asset Disposition Director, from Pfizer Inc. "We have been pleased with our past results and look forward to our upcoming participation in the BioPharma Exchange."

The GoIndustry DoveBid BioPharma Exchange is a weekly series of online auction sales. Buyers typically have 24 to 48 hours to bid on state-of-the-art, biotech lab, research & development, and pharmaceutical equipment from the world's leading pharmaceutical manufacturers including Pfizer, Merck, and Bristol-Myers Squibb Company.

The BioPharma exchanges -- featuring high quality Pfizer equipment -- are conducted weekly. For more information visit http://www.go-dove.com/exchanges/BioPharma.

To learn more about the Pfizer equipment available, contact Tom Laster at tom.laster@go-dove.com or telephone: +1 (650) 377-2646

Further information and interviews available on request

About GoIndustry DoveBid & Pfizer

GoIndustry DoveBid continues to provide asset management services for Pfizer, supporting the company's ongoing global assets recovery efforts. As a result of this relationship, Pfizer has reduced the number of surplus assets; experienced cost savings due to internal redeployment of equipment globally; and benefited from welcome cash injections from external sales. Over the past 7 years, several business units -- from Animal Health to Pfizer Global Research & Development and Global Manufacturing -- have taken advantage of this full service relationship.

GoIndustry DoveBid works with the business units to help identify surplus assets. Our expert team provides market intelligence to facilitate whether the assets are made available for redeployment internally, or for sale externally. At which point assets are appraised to give an indication their market value.

GoIndustry DoveBid offers a wide range of options for external sale including: online Auction, Private Treaty sales, or industry specific Exchanges -- a weekly series of online auction sales. Pfizer continues to be a major player in the weekly BioPharma Exchange.

About GoIndustry DoveBid

GoIndustry DoveBid is a leading provider of asset management services. If surplus or idle assets are no longer needed, we help organizations understand their worth, whether they can be re-deployed elsewhere in the business, or sell them on the used industrial goods marketplace.

GoIndustry DoveBid approaches the market with three distinct advantages. First, we have significant global reach so we are able to provide these services wherever they are needed. Second, most of our business is online, making it more efficient and convenient for both buyers and sellers whether it's for a single piece of equipment or a whole production line. Third, our knowledge of the market across multiple industry sectors is unsurpassed. Since 2000, we have collected information gathered from auctions all over the world. We leverage this rich data on a daily basis through accurate valuations and appraisals for the benefit of all our customers.

Find out more about us at www.go-dove.com or contact us to unlock the value of your assets.


'/>"/>
SOURCE GoIndustry DoveBid
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfizer Invites Public to View and Listen to Webcast of August 3 Conference Call With Analysts
2. Pfizer Prepares for Voluntary Withdrawal of U.S. New Drug Application and for Discontinuation of Commercial Availability of Mylotarg®
3. Pfizer And Epocrates Partner To Give Healthcare Providers Access To Medical Information Specialists For Medication Questions
4. Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
5. Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference
6. Pfizer Reigns Supreme After Patent Cliff as Humira Kicks Avastin off Top Spot
7. Gelesis Unveils Novel Non-Invasive Capsulated Device for Obesity and Presents Clinical Data; Appoints Former Pfizer R&D President to Board
8. Pfizers Jeffrey Kindler Becomes PhRMA Board Chairman; Christopher Viehbacher, John Lechleiter Assume New Posts
9. President of Pfizer Vaccines, Mark Swindell, Named as the Healthcare Businesswomens Associations 2010 Honorable Mentor
10. VetCentric Announces Partnership With Pfizer Animal Health
11. Pfizer Selects ChemAxons Markush Platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016  American Respiratory Labs (ARL), a ... now able to perform sophisticated lung assessments in patients, homes, thanks ... Inc. Patients are no longer limited to having ... PRO ® , ARL patients like Jeanne R. of ... the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
Breaking Medicine News(10 mins):